FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2331782482> ?p ?o ?g. }

• W2331782482 abstract "Background: The Human Epidermal Growth Factor Receptor 2 (HER2) is an oncogene expressed in 25–30% of invasive breast cancers. HER2 shares extensive homology with other members of the HER family (HER1, HER3 and HER4), and is constitutively active as an homo- and heterodimer. The HER2 gene encodes an 185kDa transmembrane protein with tyrosine kinase activity. Gene amplification or protein expression of HER2 is a predictor of poor clinical outcome and decreased survival in women with breast cancer, and also indicates a favourable response to Trastuzumab (Herceptin) therapy, or a combinational therapy comprising Herceptin plus chemotherapy. However, resistance to Trastuzumab remains the case in approximately 50% of HER2 amplified/overexpressing tumours. Understanding the molecular mechanisms of Trastuzumab resistance and identifying more effective therapies, is critical in the treatment of patients whose breast cancers express this aggressive disease phenotype. In this study, it is postulated that the abnormal generation of mRNA splice variants may be responsible for the continued tumour growth and progression. Aims: The aim of this study is to increase our understanding of the role of HER-2 splice variants in the development and progression of breast cancer. This will inform the development of more sophisticated and effective therapies that target specific HER-2 isoforms, rather than Herceptin, which targets just the generic wild type HER-2 protein. Materials and Methods: The entire coding region of HER-2 cDNA was PCR amplified using 12 sets of HER-2 specific primers in HER-2 positive cell lines (SKOV-3, SKBR-3, MDA-MB-453 and MDA-MB-361). Results: RT-PCR results showed multiple bands in various regions of the HER2 mRNA. Sequencing of these bands revealed novel alternative splice variants with deletions in exons 13 and 18 of the HER2 gene expressed in addition to the wild type HER2. Bioinformatic analysis of the deletions revealed a cassette exon deletion in exon 13, and a loss of 42 base pairs in the 3’ end of exon 18 compared to the full length HER2. Both the full length HER2 sequence and the sequence containing the deletions were translated using the ExPASy Translate Tool. This revealed an in-frame deletion of 14 amino acids and revealed a novel splice isoform with a deletion in the HER2 protein which encompasses the entire ATP binding pocket. This was determined by analysis using UniProtKB to identify the composition of amino acids for each domain of HER2. Discussion: Our studies have identified novel splice variants in the tyrosine-kinase domain of the HER-2 gene using HER-2 positive cell lines. The loss of an ATP binding site in the HER2 gene may lead to a less active HER2 isoform which may play a significant role in prognosis. Current work is being carried out to study the regulation of these splice variants and to study the role of splice factors ASF/SF2 and SRPK1 in the regulation of HER2 splicing, and to elucidate any significant changes in the HER2 signalling pathways. In addition, the expression of these isoforms are currently being investigated in tissues from formalin fixed, paraffin embedded and frozen breast tumours. Citation Information: Cancer Res 2011;71(24 Suppl):Abstract nr P5-07-01." @default.
• W2331782482 created "2016-06-24" @default.
• W2331782482 creator A5009498603 @default.
• W2331782482 creator A5025196831 @default.
• W2331782482 creator A5027053326 @default.
• W2331782482 creator A5037338885 @default.
• W2331782482 creator A5067277543 @default.
• W2331782482 date "2011-12-15" @default.
• W2331782482 modified "2023-09-26" @default.
• W2331782482 title "P5-07-01: Novel Alternative Splice Variants of HER2 in Invasive Breast Cancer." @default.
• W2331782482 doi "https://doi.org/10.1158/0008-5472.sabcs11-p5-07-01" @default.
• W2331782482 hasPublicationYear "2011" @default.
• W2331782482 type Work @default.
• W2331782482 sameAs 2331782482 @default.
• W2331782482 citedByCount "0" @default.
• W2331782482 crossrefType "proceedings-article" @default.
• W2331782482 hasAuthorship W2331782482A5009498603 @default.
• W2331782482 hasAuthorship W2331782482A5025196831 @default.
• W2331782482 hasAuthorship W2331782482A5027053326 @default.
• W2331782482 hasAuthorship W2331782482A5037338885 @default.
• W2331782482 hasAuthorship W2331782482A5067277543 @default.
• W2331782482 hasConcept C104317684 @default.
• W2331782482 hasConcept C121608353 @default.
• W2331782482 hasConcept C143998085 @default.
• W2331782482 hasConcept C194583182 @default.
• W2331782482 hasConcept C2777329042 @default.
• W2331782482 hasConcept C2779438470 @default.
• W2331782482 hasConcept C2779786085 @default.
• W2331782482 hasConcept C2781018059 @default.
• W2331782482 hasConcept C29537977 @default.
• W2331782482 hasConcept C42362537 @default.
• W2331782482 hasConcept C502942594 @default.
• W2331782482 hasConcept C530470458 @default.
• W2331782482 hasConcept C53345823 @default.
• W2331782482 hasConcept C54355233 @default.
• W2331782482 hasConcept C62478195 @default.
• W2331782482 hasConcept C71924100 @default.
• W2331782482 hasConcept C86803240 @default.
• W2331782482 hasConceptScore W2331782482C104317684 @default.
• W2331782482 hasConceptScore W2331782482C121608353 @default.
• W2331782482 hasConceptScore W2331782482C143998085 @default.
• W2331782482 hasConceptScore W2331782482C194583182 @default.
• W2331782482 hasConceptScore W2331782482C2777329042 @default.
• W2331782482 hasConceptScore W2331782482C2779438470 @default.
• W2331782482 hasConceptScore W2331782482C2779786085 @default.
• W2331782482 hasConceptScore W2331782482C2781018059 @default.
• W2331782482 hasConceptScore W2331782482C29537977 @default.
• W2331782482 hasConceptScore W2331782482C42362537 @default.
• W2331782482 hasConceptScore W2331782482C502942594 @default.
• W2331782482 hasConceptScore W2331782482C530470458 @default.
• W2331782482 hasConceptScore W2331782482C53345823 @default.
• W2331782482 hasConceptScore W2331782482C54355233 @default.
• W2331782482 hasConceptScore W2331782482C62478195 @default.
• W2331782482 hasConceptScore W2331782482C71924100 @default.
• W2331782482 hasConceptScore W2331782482C86803240 @default.
• W2331782482 hasLocation W23317824821 @default.
• W2331782482 hasOpenAccess W2331782482 @default.
• W2331782482 hasPrimaryLocation W23317824821 @default.
• W2331782482 hasRelatedWork W1517967009 @default.
• W2331782482 hasRelatedWork W1567982122 @default.
• W2331782482 hasRelatedWork W1966598152 @default.
• W2331782482 hasRelatedWork W2024079806 @default.
• W2331782482 hasRelatedWork W2035344810 @default.
• W2331782482 hasRelatedWork W2040849960 @default.
• W2331782482 hasRelatedWork W2065683374 @default.
• W2331782482 hasRelatedWork W2070165643 @default.
• W2331782482 hasRelatedWork W2071676184 @default.
• W2331782482 hasRelatedWork W2081149730 @default.
• W2331782482 hasRelatedWork W2094425921 @default.
• W2331782482 hasRelatedWork W2095659509 @default.
• W2331782482 hasRelatedWork W2170659875 @default.
• W2331782482 hasRelatedWork W2229546226 @default.
• W2331782482 hasRelatedWork W2404089974 @default.
• W2331782482 hasRelatedWork W2757914310 @default.
• W2331782482 hasRelatedWork W2786115157 @default.
• W2331782482 hasRelatedWork W2792933432 @default.
• W2331782482 hasRelatedWork W2909941416 @default.
• W2331782482 hasRelatedWork W3168310704 @default.
• W2331782482 isParatext "false" @default.
• W2331782482 isRetracted "false" @default.
• W2331782482 magId "2331782482" @default.
• W2331782482 workType "article" @default.